Clinical and Pathological Characteristics of Skin Cancer Patients at Southern Medical University, Guangzhou, China

Authors

  • Siqi Li Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong Province, China
  • Jingwen Zou Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong Province, China
  • Rongyi Chen Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong Province, China
  • Lian Zhang Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong Province, China

DOI:

https://doi.org/10.2340/actadv.v106.44550

Keywords:

tumor, basal cell carcinoma, squamous cell carcinoma., cutaneous lymphoma, melanoma

Abstract

The incidence of skin cancer is increasing in China, yet large-scale clinical and pathological data from China remain scarce. A retrospective analysis was conducted of 648 histopathologically confirmed skin cancer cases diagnosed at the Dermatology Hospital, Southern Medical University from January 2020 to July 2023. Patient demographics, tumour distribution, histological subtypes, and treatment approaches were evaluated. Squamous cell carcinoma (31.9%) and basal cell carcinoma (31.2%) were the most prevalent, followed by cutaneous lymphomas (13.9%), dendritic cell and histiocytic neoplasms (13.3%), and melanoma (9.7%). Over half of the patients (53.5%) were aged ≥ 60 years. basal cell carcinoma and squamous cell carcinoma primarily involved the head and neck, while acral sites were dominant in melanoma (79.4%). Most cases of both basal cell carcinoma and squamous cell carcinoma were managed surgically, with surgical treatment performed in 95.5% of basal cell carcinomas and 94.2% of squamous cell carcinomas. Skin cancers in China predominantly affect older adults and commonly involve sun-exposed areas. Basal cell carcinoma is typically managed surgically due to its low-risk nature, while squamous cell carcinoma demonstrates clinical heterogeneity, warranting varied treatment strategies. The higher proportion of cutaneous lymphomas among younger patients highlights the need for age-specific diagnostic and therapeutic considerations.

Downloads

Download data is not yet available.

References

Leiter U, Garbe C. Epidemiology of melanoma and nonmelanoma skin cancer: the role of sunlight. Adv Exp Med Biol 2020; 89–103. DOI: https://doi.org/10.1007/978-0-387-77574-6_8

Leiter U, Keim U, Garbe C. Epidemiology of skin cancer: update 2019. Adv Exp Med Biol 2020; 1268: 123–139. DOI: https://doi.org/10.1007/978-3-030-46227-7_6

Wang R, Chen Y, Shao X, Chen T, Zhong J, Ou Y, et al. Burden of skin cancer in older adults from 1990 to 2021 and modelled projection to 2050. JAMA Dermatol 2025; e251276. DOI: https://doi.org/10.1001/jamadermatol.2025.1276

Schmitt J, Seidler A, Diepgen TL, Bauer A. Occupational ultraviolet light exposure increases the risk for the development of cutaneous squamous cell carcinoma: a systematic review and meta-analysis: occupational UV exposure and cutaneous SCC. Br J Dermatol 2011; 164: 291–307. DOI: https://doi.org/10.1111/j.1365-2133.2010.10118.x

Liu Y, Cen Y, Xu X, Li Z. Clinical analysis of 236 cases of skin cancer. West China Med J 2007; 22: 368–369.

Huang Y, Li H, Tu P, Chen X, Yang S, Wu L, et al. Skin cancer and precancerous skin lesions: clinical analysis of 632 cases. Chinese J Dermatol 2010; 43: 452–454.

Chahal HS, Rieger KE, Sarin KY. Incidence ratio of basal cell carcinoma to squamous cell carcinoma equalizes with age. J Am Acad Dermatol 2017; 76: 353–354. DOI: https://doi.org/10.1016/j.jaad.2016.08.019

Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood 2019; 133: 1703–1714. DOI: https://doi.org/10.1182/blood-2018-11-881268

Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012; 166: 1069–1080. DOI: https://doi.org/10.1111/j.1365-2133.2012.10830.x

Rogers HW, Weinstock MA, Feldman SR, Coldiron BM. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the US population, 2012. JAMA Dermatol 2015; 151: 1081. DOI: https://doi.org/10.1001/jamadermatol.2015.1187

Madan V, Lear JT, Szeimies R-M. Non-melanoma skin cancer. Lancet 2010; 375: 673–685. DOI: https://doi.org/10.1016/S0140-6736(09)61196-X

Morita A, Lim HW, Passeron T, Goh CL, Kang HY, Ly F, et al. Attitudes and behaviors regarding sun exposure in Japan compared to Europe and North America. J Dermatol 2024; 51: 1004–1009. DOI: https://doi.org/10.1111/1346-8138.17217

Lau WC, Yang K, Lau CB, Patel S, Nambudiri VE. Characterization of sun-protective behaviours among Asian people in the USA stratified by geographic location of birth. Clin Exp Dermatol 2024; 49: 282–284. DOI: https://doi.org/10.1093/ced/llad363

Chen Z, Lin Y, Qin Y, Qu H, Zhang Q, Li Y, et al. Prognostic factors and survival outcomes among patients with mycosis fungoides in China: a 12-year review. JAMA Dermatol 2023; https://doi.org/10.1001/jamadermatol.2023.2634 DOI: https://doi.org/10.1001/jamadermatol.2023.2634

Suh KS, Jang MS, Jung JH, Kwon DI, Seong SH, Lee KH, et al. Clinical characteristics and long-term outcome of 223 patients with mycosis fungoides at a single tertiary center in Korea: a 29-year review. J Am Acad Dermatol 2022; 86: 1275–1284. DOI: https://doi.org/10.1016/j.jaad.2021.06.860

Bradford PT, Goldstein AM, McMaster ML, Tucker MA. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986–2005. Arch Dermatol 2009; 145. DOI: https://doi.org/10.1001/archdermatol.2008.609

Chang J W-C, Yeh K-Y, Wang C-H, Yang T-S, Chiang H-F, Wei F-C, et al. Malignant melanoma in Taiwan: a prognostic study of 181 cases. Melanoma Res 2004; 14: 537–541. DOI: https://doi.org/10.1097/00008390-200412000-00016

Cormier JN, Xing Y, Ding M, Lee JE, Mansfield PF, Gershenwald JE, et al. Ethnic differences among patients with cutaneous melanoma. Arch Intern Med 2006; 166: 1907. DOI: https://doi.org/10.1001/archinte.166.17.1907

Ossio R, Roldán-Marín R, Martínez-Said H, Adams DJ, Robles-Espinoza CD. Melanoma: a global perspective. Nat Rev Cancer 2017; 17: 393–394. DOI: https://doi.org/10.1038/nrc.2017.43

Behbahani S, Maddukuri S, Cadwell JB, Lambert WC, Schwartz RA. Gender differences in cutaneous melanoma: demographics, prognostic factors, and survival outcomes. Dermatol Ther 2020; 33. DOI: https://doi.org/10.1111/dth.14131

Bradford PT, Devesa SS, Anderson WF, Toro JR. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood 2009; 113: 5064–5073. DOI: https://doi.org/10.1182/blood-2008-10-184168

Bekkenk MW, Geelen FAMJ, Vader PCVV, Heule F, Geerts M-L, Van Vloten WA, et al. Primary and secondary cutaneous CD30+lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood 2000; 95: 3653–3661. DOI: https://doi.org/10.1182/blood.V95.12.3653.012k23_3653_3661

Shi H-Z, Liu Y-X, Jiang Y-Q, Chen S-L, Xu X-L, Lu X-M, et al. Clinical characteristics of primary cutaneous lymphoma: analysis from two centres in China. Br J Dermatol 2019; 181: 1332–1333. DOI: https://doi.org/10.1111/bjd.18266

Apalla Z, Nashan D, Weller RB, Castellsagué X. Skin cancer: epidemiology, disease burden, pathophysiology, diagnosis, and therapeutic approaches. Dermatol Ther (Heidelb) 2017; 7: 5–19. DOI: https://doi.org/10.1007/s13555-016-0165-y

Kimura H, Fujiwara S. Overview of EBV-associated T/NK-cell lymphoproliferative diseases. Front Pediatr 2019; 6: 417. DOI: https://doi.org/10.3389/fped.2018.00417

Lai W, Wang Y, Wang J, Wu L, Jin Z, Wang Z. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults and adolescents – a life-threatening disease: analysis of 133 cases from a single center. Hematology 2018; 23: 810–816. DOI: https://doi.org/10.1080/10245332.2018.1491093

Kimura H, Ito Y, Kawabe S, Gotoh K, Takahashi Y, Kojima S, et al. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood 2012; 119: 673–686. DOI: https://doi.org/10.1182/blood-2011-10-381921

Salari B, Dehner LP. Juvenile and adult xanthogranuloma: a 30-year single-center experience and review of the disorder and its relationship to other histiocytoses. Ann Diagn Pathol 2022; 58: 151940. DOI: https://doi.org/10.1016/j.anndiagpath.2022.151940

Kundak S, Çakır Y. Juvenile xanthogranuloma: retrospective analysis of 44 pediatric cases (single tertiary care center experience). Int J Dermatol 2021; 60: 564–569. DOI: https://doi.org/10.1111/ijd.15223

Published

2026-02-17

How to Cite

Li, S., Zou, J., Chen, R., & Zhang, L. (2026). Clinical and Pathological Characteristics of Skin Cancer Patients at Southern Medical University, Guangzhou, China. Acta Dermato-Venereologica, 106, adv44550. https://doi.org/10.2340/actadv.v106.44550

Issue

Section

Articles

Categories